Completing the Translation
- PMID: 32162829
- PMCID: PMC7066685
- DOI: 10.1634/theoncologist.2019-0650
Completing the Translation
Erratum in
-
Completing the Translation.Oncologist. 2020 May;25(5):e878. doi: 10.1634/theoncologist.2020-0217. Oncologist. 2020. PMID: 33404116 Free PMC article. No abstract available.
Abstract
Comprehensive standards and guidelines for generating and reporting laboratory results are needed, especially as related to the translation of biology to precision medicine. This commentary focuses on the topic, highlighting a new study that investigated laboratories reporting next‐generation sequencing results to clinicians.
Conflict of interest statement
Comment on
-
From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis.Oncologist. 2020 Mar;25(3):218-228. doi: 10.1634/theoncologist.2019-0239. Epub 2019 Aug 30. Oncologist. 2020. PMID: 32162803 Free PMC article.
References
-
- Crowley E, Di Nicolantonio F, Loupakis F et al. Liquid biopsy: monitoring cancer genetics in the blood. Nat Rev Clin Oncol 2013;10:472–484. - PubMed
